SG Americas Securities, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 1 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10
+400.0%
81,598
+284.4%
0.00%
Q4 2022$2
-100.0%
21,228
-82.1%
0.00%
Q3 2022$18,000
-30.8%
118,918
+303.9%
0.00%
Q2 2022$26,000
-82.4%
29,443
-75.3%
0.00%
-100.0%
Q1 2022$148,000
+87.3%
119,157
+194.5%
0.00%
Q4 2021$79,000
-62.0%
40,460
-46.7%
0.00%
-100.0%
Q3 2021$208,000
+617.2%
75,925
+416.5%
0.00%
Q4 2020$29,00014,7000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders